BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  Results Of Phase 1a/1b Study Of AbbVie’s Investigational Medicine Rovalpituzumab Tesirine (Rova-T) Showed Overall Response Rate Of 39 Percent In Pretreated Patients With Biomarker-Defined Small Cell Lung Cancer (SCLC)

  June 6, 2016

   · 

  8 min read
• Drug Development

  ASCO2016: Kite Pharma Announces The First Meta-Analysis Of Outcomes In Chemorefractory Diffuse Large B-Cell Lymphoma (SCHOLAR-1)

  June 6, 2016

   · 

  5 min read
• Drug Development

  ASCO2016: Merrimack Release: Final Analysis Of First-In-Human Phase 1 Study Of MM-151 Shows Positive Clinical Activity In Multiple Solid Tumor Types, Including Colorectal Cancer

  June 6, 2016

   · 

  8 min read
• Drug Development

  ASCO2016: Kite Pharma Presents Ongoing Complete Responses At 9 Months In Phase I Of ZUMA-1 In Patients With Chemorefractory Non-Hodgkin Lymphoma

  June 6, 2016

   · 

  5 min read
• Finesse Solutions SmartFactory Platform Featured In Alvotech Opening Of New Manufacturing And Lab Facility In Iceland

  June 6, 2016

   · 

  3 min read
• Drug Development

  ASCO2016: SELLAS Life Sciences Group Announces Exciting Results For Galinpepimut-S, The Company’s WT1 Vaccine, In Patients With Acute Myeloid Leukemia (AML) And Malignant Pleural Mesothelioma (MPM), As Presented At The 2016 ASCO Annual Meeting

  June 6, 2016

   · 

  8 min read
• Drug Development

  ASCO2016: Principia Biopharma Announces Presentation Of Initial Clinical Data On PRN1371 At 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting

  June 6, 2016

   · 

  2 min read
• Drug Development

  Ipsen Release: Endocrine Practice Publishes ELECT Phase III Trial Results In Adults With Carcinoid Syndrome

  June 6, 2016

   · 

  10 min read
• Drug Development

  ASCO2016: Incyte Release: Five-Year Results From Phase III Study Of Jakafi (Ruxolitinib) Show Sustained Overall Survival Benefit In Patients With Myelofibrosis (MF)

  June 6, 2016

   · 

  8 min read
• Pharm Country

  NYU Langone Medical Center Release: Study Shows Why Immune-Boosting Therapy Doesn’t Work For Everyone With Widespread Melanoma

  June 6, 2016

   · 

  4 min read